|
|
||||||||
The Journal of Immunology, Vol 147, Issue 7 2175-2180, Copyright © 1991 by American Association of Immunologists
ARTICLES |
TJ Brown, JM Rowe, JW Liu and M Shoyab
Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, WA 98121.
Endothelial cells produce immunomodulatory cytokines in response to soluble mediators of inflammatory/immune reactions. We have previously demonstrated that the leukocyte-derived cytokine, oncostatin M (Onco M) can alter endothelial cell morphology, regeneration, and fibrinolytic activity in vitro. Here we demonstrate that Onco M stimulates the production of the pleiotropic cytokine, IL-6, in cultured human endothelial cells (HEC) in a time- and dose-dependent manner. Specific antibodies to IL-6 neutralize the growth-inhibitory activity for human breast carcinoma cells that is secreted by HEC in response to Onco M treatment. Specific immunoassays indicate greater than 10-fold increases in the IL-6 content of culture supernatants as early as 6 h post-treatment with Onco M (ED50 = 17 pM). This stimulation of IL-6 production by Onco M is associated with a sevenfold increase in intracellular levels of IL-6 mRNA. IL-1 alpha and TNF-alpha are also potent inducers of IL-6 production in these cells, the order of potency being IL-1 alpha greater than Onco M greater than TNF-alpha. TNF-alpha, but not IL-1 alpha, synergizes with Onco M to augment IL-6 production in HEC. HEC are 10 to 20 times more responsive to Onco M than are other nonendothelial cell types. In addition, HEC express 10 to 20 times greater numbers of high affinity cell-surface receptors for Onco M than do other nonendothelial cell types. Based on these findings, we propose that Onco M may represent a new immunomodulator regulating cytokine- induced gene products in endothelial cells.
This article has been cited by other articles:
![]() |
V. A. Luyckx, L. V. Cairo, C. A. Compston, W. L. Phan, and T. F. Mueller Oncostatin M pathway plays a major role in the renal acute phase response Am J Physiol Renal Physiol, April 1, 2009; 296(4): F875 - F883. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hamada, A. Sato, T. Hirano, T. Yamamoto, G. Son, M. Onodera, I. Torii, T. Nishigami, M. Tanaka, A. Miyajima, et al. Oncostatin M Gene Therapy Attenuates Liver Damage Induced by Dimethylnitrosamine in Rats Am. J. Pathol., September 1, 2007; 171(3): 872 - 881. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Smyth, C. Kerr, and C. D. Richards Oncostatin M-Induced IL-6 Expression in Murine Fibroblasts Requires the Activation of Protein Kinase C{delta} J. Immunol., December 15, 2006; 177(12): 8740 - 8747. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yao, T. Yokota, L. Xia, P. W. Kincade, and R. P. McEver Bone marrow dysfunction in mice lacking the cytokine receptor gp130 in endothelial cells Blood, December 15, 2005; 106(13): 4093 - 4101. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Faffe, L. Flynt, M. Mellema, T. R. Whitehead, K. Bourgeois, R. A. Panettieri Jr., E. S. Silverman, and S. A. Shore Oncostatin M causes VEGF release from human airway smooth muscle: synergy with IL-1{beta} Am J Physiol Lung Cell Mol Physiol, June 1, 2005; 288(6): L1040 - L1048. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yuan, F. J. Liddle, S. Mahajan, and D. A. Frank IL-6-induced survival of colorectal carcinoma cells is inhibited by butyrate through down-regulation of the IL-6 receptor Carcinogenesis, November 1, 2004; 25(11): 2247 - 2255. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nagata, H. Kai, R. Shibata, M. Koga, A. Yoshimura, and T. Imaizumi Oncostatin M, an Interleukin-6 Family Cytokine, Upregulates Matrix Metalloproteinase-9 Through the Mitogen-Activated Protein Kinase Kinase-Extracellular Signal-Regulated Kinase Pathway in Cultured Smooth Muscle Cells Arterioscler Thromb Vasc Biol, April 1, 2003; 23(4): 588 - 593. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Hurst, R. M. McLoughlin, J. Monslow, S. Owens, L. Morgan, G. M. Fuller, N. Topley, and S. A. Jones Secretion of Oncostatin M by Infiltrating Neutrophils: Regulation of IL-6 and Chemokine Expression in Human Mesothelial Cells J. Immunol., November 1, 2002; 169(9): 5244 - 5251. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Ensoli, V Fiorelli, A Lugaresi, D Farina, M DeCristofaro, B Collacchi, D S. Muratori, E Scala, M Di Gioacchino, R Paganelli, et al. Lymphomononuclear cells from multiple sclerosis patients spontaneously produce high levels of oncostatin M, tumor necrosis factors {alpha} and {beta}, and interferon {gamma} Multiple Sclerosis, August 1, 2002; 8(4): 284 - 288. [Abstract] [PDF] |
||||
![]() |
K. Mahboubi and J. S. Pober Activation of Signal Transducer and Activator of Transcription 1 (STAT1) Is Not Sufficient for the Induction of STAT1-dependent Genes in Endothelial Cells. COMPARISON OF INTERFERON-gamma AND ONCOSTATIN M J. Biol. Chem., March 1, 2002; 277(10): 8012 - 8021. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Somasundaram, M. Ruehl, B. Schaefer, M. Schmid, R. Ackermann, E. O. Riecken, M. Zeitz, and D. Schuppan Interstitial Collagens I, III, and VI Sequester and Modulate the Multifunctional Cytokine Oncostatin M J. Biol. Chem., January 25, 2002; 277(5): 3242 - 3246. [Abstract] [Full Text] [PDF] |
||||
![]() |
A F Wahl and P M Wallace Oncostatin M in the anti-inflammatory response Ann Rheum Dis, November 1, 2001; 60(90003): iii75 - 80. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nishibe, G. Parry, A. Ishida, S. Aziz, J. Murray, Y. Patel, S. Rahman, K. Strand, K. Saito, Y. Saito, et al. Oncostatin M promotes biphasic tissue factor expression in smooth muscle cells: evidence for Erk-1/2 activation Blood, February 1, 2001; 97(3): 692 - 699. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Langdon, C. Kerr, M. Hassen, T. Hara, A. L. Arsenault, and C. D. Richards Murine Oncostatin M Stimulates Mouse Synovial Fibroblasts in Vitro and Induces Inflammation and Destruction in Mouse Joints in Vivo Am. J. Pathol., October 1, 2000; 157(4): 1187 - 1196. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Inserra, M. Yao, R. Murray, and D. J. Terris Peripheral Nerve Regeneration in Interleukin 6-Deficient Mice Arch Otolaryngol Head Neck Surg, September 1, 2000; 126(9): 1112 - 1116. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ihn and K. Tamaki Oncostatin M Stimulates the Growth of Dermal Fibroblasts Via a Mitogen-Activated Protein Kinase-Dependent Pathway J. Immunol., August 15, 2000; 165(4): 2149 - 2155. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Mahboubi, B. C. Biedermann, J. M. Carroll, and J. S. Pober IL-11 Activates Human Endothelial Cells to Resist Immune-Mediated Injury J. Immunol., April 1, 2000; 164(7): 3837 - 3846. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bernard, R. Merval, M. Lebret, P. Delerive, I. Dusanter-Fourt, S. Lehoux, C. Creminon, B. Staels, J. Maclouf, and A. Tedgui Oncostatin M Induces Interleukin-6 and Cyclooxygenase-2 Expression in Human Vascular Smooth Muscle Cells : Synergy With Interleukin-1{beta} Circ. Res., December 3, 1999; 85(12): 1124 - 1131. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yao, H. Setiadi, L. Xia, Z. Laszik, F. B. Taylor, and R. P. McEver Divergent Inducible Expression of P-Selectin and E-Selectin in Mice and Primates Blood, December 1, 1999; 94(11): 3820 - 3828. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Vasse, J. Pourtau, V. Trochon, M. Muraine, J.-P. Vannier, H. Lu, J. Soria, and C. Soria Oncostatin M Induces Angiogenesis In Vitro and In Vivo Arterioscler Thromb Vasc Biol, August 1, 1999; 19(8): 1835 - 1842. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Murphy, L. S. Borthwick, R. S. Johnston, G. Kuchel, and P. M. Richardson Nature of the Retrograde Signal from Injured Nerves that Induces Interleukin-6 mRNA in Neurons J. Neurosci., May 15, 1999; 19(10): 3791 - 3800. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Wallace, J. F. MacMaster, K. A. Rouleau, T. J. Brown, J. K. Loy, K. L. Donaldson, and A. F. Wahl Regulation of Inflammatory Responses by Oncostatin M J. Immunol., May 1, 1999; 162(9): 5547 - 5555. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Loy, T. J. Davidson, K. K. Berry, J. F. Macmaster, B. Danle, and S. K. Durham Oncostatin M: Development of a Pleiotropic Cytokine Toxicol Pathol, March 1, 1999; 27(2): 151 - 155. [Abstract] [PDF] |
||||
![]() |
O. Saijonmaa, T. Nyman, P. Pacek, and F. Fyhrquist Oncostatin M regulates endothelin-1 production in human endothelial cells Am J Physiol Heart Circ Physiol, August 1, 1998; 275(2): H662 - H667. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Korzus, H. Nagase, R. Rydell, and J. Travis The Mitogen-activated Protein Kinase and JAK-STAT Signaling Pathways Are Required for an Oncostatin M-responsive Element-mediated Activation of Matrix Metalloproteinase 1Gene Expression J. Biol. Chem., January 10, 1997; 272(2): 1188 - 1196. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Wijelath, B Carlsen, T Cole, J Chen, S Kothari, and W. Hammond Oncostatin M induces basic fibroblast growth factor expression in endothelial cells and promotes endothelial cell proliferation, migration and spindle morphology J. Cell Sci., January 4, 1997; 110(7): 871 - 879. [Abstract] [PDF] |
||||
![]() |
S. Miles, O Martinez-Maza, A Rezai, L Magpantay, T Kishimoto, S Nakamura, S. Radka, and P. Linsley Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells Science, March 13, 1992; 255(5050): 1432 - 1434. [Abstract] [PDF] |
||||
![]() |
A. Rhodes, A. Deakin, J. Spaull, B. Coomber, A. Aitken, P. Life, and S. Rees The Generation and Characterization of Antagonist RNA Aptamers to Human Oncostatin M J. Biol. Chem., September 8, 2000; 275(37): 28555 - 28561. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |